• Diagnosis​ Info ​and​ ​General​ ​Questions

  Adakveo for SCD Being Tested in Series of Trials, Including at Higher Dose and in Children

  Posted by Sickle Cell Forum Administrator on March 30, 2021 at 9:00 am

  

  Novartis is continuing to test Adakveo, approved to treat pain crises in sickle cell, at a higher dose, in kids, and in those with specific complications. Click here to learn more.

  Did you enjoy this article?

  Sickle Cell Forum Administrator replied 4 years, 7 months ago 0 Member · 0 Replies

  • Research
• 0 Replies

Log In to Reply